In this study, the ufmylation of RPL10 was confirmed in the tissues of PAAD patients and pancreatic cancer cell lines, and this modification was mediated by UFL1 at specific sites and cleaved by UFSP2. The gene discussed is RPL10; the disease is pancreatic adenocarcinoma.